A brief case series of radiation associated myelopathy

Sena D Bünül1, Cansu E Sarıkaya1, Onural Öztürk1

  • 1From the Department of Neurology (Bünül, Sarıkaya), Faculty of Medicine, Kocaeli University, Kocaeli, from the Department of Neurosurgery (Sarıkaya), University of Health Sciences Istanbul Umraniye Training and Research Hospital, and from Seka State Hospital (Öztürk), Kocaeli, Turkey.

Insights

Radiation myelopathy (RM) is a rare complication of radiotherapy. This study found no clinical improvement in patients with radiation myelitis despite aggressive treatment, highlighting the condition's severity.

Area of Science:

  • Neurology
  • Radiotherapy
  • Oncology

Background:

  • Radiation myelopathy (RM) is a rare but severe complication following radiotherapy.
  • Pathophysiology involves small vessel ischemia and demyelination.
  • RM is a diagnosis of exclusion, requiring differentiation from infectious, neoplastic, rheumatic, and paraneoplastic causes.

Purpose of the Study:

  • To report on three patients diagnosed with radiation myelitis.
  • To illustrate the clinical presentation and diagnostic challenges of RM.

Main Methods:

  • Case report of three patients with radiation myelitis.
  • Diagnosis confirmed via contrast-enhanced magnetic resonance imaging (MRI).
  • Clinical outcomes assessed one year post-treatment.

Main Results:

  • All patients presented with late-onset paraparesis and paresthesia.
  • Standard treatments including high-dose steroids, hyperbaric oxygen, and physical therapy yielded no clinical improvement.
  • Lack of response observed at one-year follow-up.

Conclusions:

  • Radiation myelitis presents with significant neurological deficits.
  • Current treatment modalities show limited efficacy in improving outcomes for radiation myelitis.
  • Further research into novel therapeutic strategies for RM is warranted.

Related Concept Videos